Monitoring : Regular blood tests to track hormonal changes and adjust dosing accordingly
According to the Mayo Clinic, women with a BMI over 30 have an increased risk of the following: Miscarriage (which can increase by up to 50% in BMIs over 35) Gestational diabetes Preeclampsia Heart conditions Sleep apnea C-section surgery upon delivery There is no exact number that guarantees infertility or pregnancy problems
According to the FDA, studies have shown that when taken as prescribed, Semaglutide is a safe medication, has low risks of severe adverse events, and can be taken by most individuals
Tirzepatide (Mounjaro, Zepbound) Tirzepatide adds GIP receptor activation to GLP-1 agonism, creating a dual mechanism that achieves approximately 21% weight loss in trials
Consult your physician if you have Lebers optic neuropathy, polycythemia, gout, iron or folic acid deficiency anemia or hypokalemia
The potential delay factor is the triple-agonist novelty